首页 | 本学科首页   官方微博 | 高级检索  
检索        

氯沙坦钾对糖尿病肾病大鼠肾组织p-JAK2、p-STAT3及VEGF表达的影响
引用本文:刘明,张晓东,方敬爱,孙艳艳,刘文媛.氯沙坦钾对糖尿病肾病大鼠肾组织p-JAK2、p-STAT3及VEGF表达的影响[J].中国中西医结合肾病杂志,2014(8):669-671.
作者姓名:刘明  张晓东  方敬爱  孙艳艳  刘文媛
作者单位:山西医科大学第一医院肾内科,太原030001
基金项目:本课题为国际科技合作项目(No.2011081066))
摘    要:目的:探讨氯沙坦钾对糖尿病肾病(diabetic nephropathy,DN)大鼠肾组织 p - JAK2、p - STAT3及 VEGF 表达的影响。方法:健康雄性 SD 大鼠30只随机分为正常对照组(C 组)、DN 模型组(DN 组)、氯沙坦钾组(L 组)。采用单次腹腔内注射链脲佐菌素(streptozotocin,STZ)法建立 DN 大鼠模型,周期12周。实验12周末检测大鼠血糖、Scr、BUN、24 h 尿蛋白定量;光镜及电镜下观察大鼠肾组织病理改变;采用免疫组化方法检测大鼠肾组织 p - JAK2、p - STAT3、VEGF 表达。结果:实验12周末,模型组大鼠血糖、Scr、BUN、24 h 尿蛋白定量均高于对照组(P ﹤0.05),肾组织中 p - JAK2、p - STAT3、VEGF 表达均高于对照组(P ﹤0.05);氯沙坦钾组大鼠 Scr、BUN、24 h 尿蛋白定量均低于模型组(P ﹤0.05),肾组织 p - JAK2、p -STAT3、VEGF 表达均低于模型组(P ﹤0.05)。结论:氯沙坦钾可能部分通过调控 p - JAK2、p - STAT3及 VEGF 的表达而发挥肾脏保护作用。

关 键 词:氯沙坦钾糖尿病肾病p-JAK2  p-STAT3  VEGF

Effect of Losartan Potassium on p - JAK2,p - STAT3 and VEGF of Renal Tissue in the Diabetic Nephropathy Rats
Institution:LIU Ming, ZHANG Xiaodong, FANG Jingai, et al (Department of Nephrology, First Affiliated Hospital, Shanxi Medical University, Taiyuan (030001 ))
Abstract:Objective:To investigate the effect of Losartan Potassium on p - JAK2,p - STAT3 and VEGF of renal tissue in the diabetic nephropathy rats. Methods:30 SD male rats were divided randomly into control group(group C),diabetic nephropathy group(group DN),Losartan Potassium group(group L). The rats were being intraperitoneal injected with STZ(1% ,45 mg/ kg)to establish diabetic nephropathy rats models,test period 12 weeks. Blood glucose,Scr,BUN,24 - hour urinary protein were measured at the 12th. The renal pathological changes were detected by light microscope and electron microscopy. The expression of p - JAK2, p - STAT3 and VEGF were detected by immunohistochemistry staining sections. Results:After establishing mode for 12 weeks,com-pared with group C,group DN had significant elevated blood glucose,24 - hour urinary protein,Scr,BUN(P ﹤ 0. 05),and immuno-histochemistry staining displayed that the expression of p - JAK2,p - STAT3,VEGF remarkably increased(P ﹤ 0. 05). Compared with group DN,group L had significantly lower 24 urinary protein,Scr,BUN(P ﹤ 0. 05),the expression of p - JAK2,p - STAT3, VEGF were lower than those in group DN(P ﹤ 0. 05). Conclusion:Losartan Potassium may in part through regulating the expression of p - JAK2,p - STAT3 and VEGF play a protective role in the kidney of diabetic nephropathy rats.
Keywords:VEGF  Losartan potassium  Diabetic nephropathy  VEGF
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号